Atlas Trials

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Clinical trial NCT07288749 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07288749
Sponsor
Tongji Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)Chronic Heart Failure (CHF)
Start date
2026-01-01
Primary completion
2030-12-31
Enrollment
1484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.